Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2025-12-25 @ 10:56 PM
NCT ID: NCT00789867
Description: None
Frequency Threshold: 5
Time Frame: 28 days
Study: NCT00789867
Study Brief: Single Dose of pGM169/GL67A in CF Patients
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
20ml pGM169/GL67A Received a nebulized dose 20ml via an breath-actuated nebulizer 0 None 1 17 14 17 View
10ml pGM169/GL67A Received a nebulized dose 10ml via an breath-actuated nebulizer 0 None 1 10 7 10 View
5ml pGM169/GL67A Received a nebulized dose 5ml via an breath-actuated nebulizer 0 None 0 8 1 8 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Acute pancreatitis SYSTEMATIC_ASSESSMENT Endocrine disorders MedDRA 10.0 View
Injury in luvula sustained from pressure of tube during bronchoscopy 03/04/2009 SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 10.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Mild self limiting influenza like systemic response SYSTEMATIC_ASSESSMENT Immune system disorders MedDRA 10.0 View